With over 350,000 out-of-hospital cardiac arrests (OHCA) per year, identifying a medication with demonstrated efficacy could save tens of thousands of lives annually. This Journal Club evaluates the data behind sodium nitrite for use in reperfusion following ischemia due to cardiac arrest.

Upon successful completion of this application-based course, participants should be able to:
1. Explain the mechanism of action of sodium nitrite.
2. Describe the significance of out-of-hospital cardiac arrest and its incidence in the United States.
3. Discuss the statistical findings of the SNOCAT trial and the current clinical significance of using sodium nitrite for the treatment of out-of-hospital cardiac arrest.
4. Apply the results of the SNOCAT trial to a patient case. 

Dan Hu, PharmD, BCCCP
Critical Care and Emergency Medicine
Owner, Dan Hu Consulting, LLC

Dr. Hu does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course. 

To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the article cited below, attend the live webinar, successfully pass the exam*, and complete the final course evaluation.
*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

ARTICLE: Kim F, Maynard C, Nichol G. Effect of Sodium Nitrite on Survival of Cardiac Arrest to Hospital Admission—Reply. JAMA. 2021;325(20):2118–2119. doi:10.1001/jama.2021.4067

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: January 12, 2022
Planned Expiration Date: January 12, 2025

Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

RV2-08.23